Miravo Healthcare™ Announces Third Quarter 2021 Results Release Date and Conference Call Details

Mississauga, Ontario, Canada – November 1, 2021 – Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2021 financial results before markets open on Monday, November 15, 2021.

The Company will subsequently hold a conference call the same day, Monday, November 15, 2021 at 11:00 a.m. ET, hosted by Jesse Ledger, Miravo’s President & Chief Executive Officer and other senior management.  A question-and-answer session will follow the corporate update.


DATE: Monday, November 15, 2021

TIME:  11:00 a.m. ET

DIAL-IN NUMBERS:   (289) 536-4777 or 1 (888) 550-2239

The audio webcast and webcast replay can be accessed at:



About Miravo Healthcare

Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.  The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology.  The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.  Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada.  The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.  For additional information, please visit www.miravohealthcare.com.



Investor Relations
Stefan Eftychiou
905 326 1888 ext 60